Roeland Nusse's most recent trade in Bio-Techne Corp was a trade of 17,040 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Aug. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Roeland Nusse | Director | 25 Aug 2025 | 17,040 | 0 | - | - | Stock Options (Right to Buy) | ||
| Bio-Techne | Roeland Nusse | Director | 25 Aug 2025 | 17,040 | 44,559 (0%) | 0% | 56.4 | 960,388 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 25 Aug 2025 | 17,040 | 61,599 (0%) | 0% | 21.8 | 372,154 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | ||
| Bio-Techne | Roeland Nusse | Director | 24 Oct 2024 | 1,462 | 44,559 (0%) | 0% | 0 | Common Stock | ||
| Bio-Techne | Roeland Nusse | Director | 07 Mar 2024 | 10,400 | 43,097 (0%) | 0% | 77.0 | 800,627 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 19 Apr 2023 | 377 | 28,811 (0%) | 0% | 0 | Common Stock | ||
| Bio-Techne | Roeland Nusse | Director | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | ||
| Bio-Techne | Roeland Nusse | Director | 27 Oct 2022 | 338 | 7,297 (0%) | 0% | 0 | Common Stock | ||
| Bio-Techne | Roeland Nusse | Director | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | ||
| Bio-Techne | Roeland Nusse | Director | 28 Oct 2021 | 194 | 6,959 (0%) | 0% | 0 | Common Stock | ||
| Bio-Techne | Roeland Nusse | Director | 23 Aug 2021 | 4,000 | 0 | - | - | Stock Option (right to buy) | ||
| Bio-Techne | Roeland Nusse | Director | 23 Aug 2021 | 4,000 | 6,765 (0%) | 0% | 481.5 | 1,926,065 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 23 Aug 2021 | 4,000 | 10,765 (0%) | 0% | 70.4 | 281,400 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 08 Feb 2021 | 6,000 | 6,765 (0%) | 0% | 385.1 | 2,310,481 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 08 Feb 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | ||
| Bio-Techne | Roeland Nusse | Director | 08 Feb 2021 | 5,000 | 12,765 (0%) | 0% | 66.9 | 334,500 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | 08 Feb 2021 | 1,000 | 4,000 | - | - | Stock Option (right to buy) | ||
| Bio-Techne | Roeland Nusse | Director | 08 Feb 2021 | 1,000 | 7,765 (0%) | 0% | 70.4 | 70,350 | Common Stock |